1 BTC
=
- USD
ACELYRIN, INC. Common Stock
As of May 30, 2026 at 24:05 UTC
Chart
About ACELYRIN, INC. Common Stock
Acelyrin Inc is a late-stage clinical biopharmaceutical company. The clinical biopharma segment researches and develops treatments for diseases with pathology related to excess activation of the immune system. It is focused on providing patients with life-changing new treatment options by identifying, acquiring, and accelerating the development and commercialization of transformative medicines.
Market Statistics
Trading Metrics
How to Buy SLRN
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy SLRN
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articles
ACELYRIN reiterates the benefits of its proposed merger with Alumis, stating that the combination will create a leading clinical-stage immunology company with a diversified portfolio and substantial runway to reach multiple value inflection points. The ACELYRIN board unanimously recommends that stockholders vote in favor of the merger.